CCR2 and glaucoma: This is supported by a previous study [3] by Chong et al., where the application of MCP-1 receptor inhibitor (MCP-Ri) resulted in a marked reduction in the number of monocytes and monocyte-derived macrophages in a preclinical model of glaucoma filtration surgery (GFS).